Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Ocular Therapeutix data 'paint a compelling profile,' says Piper Sandler » 16:33
09/29/22
09/29
16:33
09/29/22
16:33
OCUL

Ocular Therapeutix

$5.13 /

+1.005 (+24.36%)

After Ocular Therapeutix…

After Ocular Therapeutix presented additional details from the Phase Ib randomized study of OTX-TKI versus aflibercept in wAMD at Eyecelerator, Piper Sandler analyst Joseph Catanzaro note that the presentation included a detailed swimmer's plot that "clearly showed" the extent of injection burden for the 12-months prior to study enrollment and the subsequent 93% reduction in treatment burden while on study. The analyst, who contends that the added data "paint a compelling profile" and "further solidify OTX-TKI as what we already saw as a best-in-class program," keeps an Overweight rating and $10 price target on Ocular shares.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$5.13 /

+1.005 (+24.36%)

OCUL Ocular Therapeutix
$5.13 /

+1.005 (+24.36%)

09/27/22 Piper Sandler
Ocular Therapeutix hit/beat on Phase I study expectations, says Piper Sandler
08/10/22 Berenberg
Ocular Therapeutix assumed with a Buy at Berenberg
05/27/22 Piper Sandler
Ocular Therapeutix price target lowered to $10 from $16 at Piper Sandler
05/10/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $10 from $14 at H.C. Wainwright
OCUL Ocular Therapeutix
$5.13 /

+1.005 (+24.36%)

OCUL Ocular Therapeutix
$5.13 /

+1.005 (+24.36%)

Over a week ago
On The Fly
What You Missed On Wall Street On Tuesday » 16:37
09/27/22
09/27
16:37
09/27/22
16:37
HTZ

Hertz

$16.50 /

+0.67 (+4.23%)

, BP

BP

$27.56 /

+0.295 (+1.08%)

, PFS

Provident Financial

$20.27 /

-2.915 (-12.58%)

, LBAI

Lakeland Bancorp

$16.38 /

+0.07 (+0.43%)

, JBL

Jabil

$57.40 /

+1.24 (+2.21%)

, BIIB

Biogen

$197.75 /

+1.985 (+1.01%)

, F

Ford

$11.92 /

-0.08 (-0.67%)

, KDP

Keurig Dr Pepper

$35.96 /

-1.325 (-3.55%)

, H

Hyatt

$80.56 /

+2.34 (+2.99%)

, LCID

Lucid Group

$14.42 /

+0.38 (+2.71%)

, CSX

CSX

$27.23 /

-0.215 (-0.78%)

, NSC

Norfolk Southern

$213.86 /

-1.03 (-0.48%)

, LEV

Lion Electric

$2.98 /

+0.11 (+3.83%)

, TSLA

Tesla

$283.03 /

+7.2 (+2.61%)

, IHG

InterContinental

$47.83 /

+0.69 (+1.46%)

, TSM

TSMC

$72.98 /

-0.14 (-0.19%)

, GS

Goldman Sachs

$291.60 /

-3.11 (-1.06%)

, APO

Apollo Global

$48.84 /

-0.08 (-0.16%)

, SKIN

Beauty Health

$11.58 /

+1.18 (+11.35%)

, NVAX

Novavax

$20.04 /

+1.18 (+6.26%)

, HROW

Harrow Health

$9.74 /

+2.16 (+28.50%)

, RNA

Avidity Biosciences

$16.70 /

-2.07 (-11.03%)

, OCUL

Ocular Therapeutix

$4.29 /

-0.985 (-18.69%)

, CBRL

Cracker Barrel

$97.20 /

-0.66 (-0.67%)

, UNFI

United Natural Foods

$37.33 /

-1.135 (-2.95%)

, AVNT

Avient

$31.04 /

-1.885 (-5.73%)

, SNX

TD Synnex

$84.39 /

+0.23 (+0.27%)

, SPLK

Splunk

$80.38 /

+1.03 (+1.30%)

, R

Ryder

$76.22 /

+9.625 (+14.45%)

Get caught up quickly on…

ShowHide Related Items >><<
UNFI United Natural Foods
$37.33 /

-1.135 (-2.95%)

TSM TSMC
$72.98 /

-0.14 (-0.19%)

TSLA Tesla
$283.03 /

+7.2 (+2.61%)

SPLK Splunk
$80.38 /

+1.03 (+1.30%)

SNX TD Synnex
$84.39 /

+0.23 (+0.27%)

SKIN Beauty Health
$11.58 /

+1.18 (+11.35%)

RNA Avidity Biosciences
$16.70 /

-2.07 (-11.03%)

R Ryder
$76.22 /

+9.625 (+14.45%)

PFS Provident Financial
$20.27 /

-2.915 (-12.58%)

OCUL Ocular Therapeutix
$4.29 /

-0.985 (-18.69%)

NVAX Novavax
$20.04 /

+1.18 (+6.26%)

NSC Norfolk Southern
$213.86 /

-1.03 (-0.48%)

LEV Lion Electric
$2.98 /

+0.11 (+3.83%)

LCID Lucid Group
$14.42 /

+0.38 (+2.71%)

LBAI Lakeland Bancorp
$16.38 /

+0.07 (+0.43%)

KDP Keurig Dr Pepper
$35.96 /

-1.325 (-3.55%)

JBL Jabil
$57.40 /

+1.24 (+2.21%)

IHG InterContinental
$47.83 /

+0.69 (+1.46%)

HTZ Hertz
$16.50 /

+0.67 (+4.23%)

HROW Harrow Health
$9.74 /

+2.16 (+28.50%)

H Hyatt
$80.56 /

+2.34 (+2.99%)

GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

F Ford
$11.92 /

-0.08 (-0.67%)

CSX CSX
$27.23 /

-0.215 (-0.78%)

CBRL Cracker Barrel
$97.20 /

-0.66 (-0.67%)

BP BP
$27.56 /

+0.295 (+1.08%)

BIIB Biogen
$197.75 /

+1.985 (+1.01%)

AVNT Avient
$31.04 /

-1.885 (-5.73%)

APO Apollo Global
$48.84 /

-0.08 (-0.16%)

HTZ Hertz
$16.50 /

+0.67 (+4.23%)

08/10/22 Tigress Financial
Tigress Financial raises Hertz price target to $34 on favorable industry trends
07/29/22 Deutsche Bank
Hertz price target raised to $38 from $29 at Deutsche Bank
07/14/22 Morgan Stanley
Hertz price target lowered to $16 from $23 at Morgan Stanley
07/13/22 Deutsche Bank
Hertz price target lowered to $29 from $36 at Deutsche Bank
BP BP
$27.56 /

+0.295 (+1.08%)

09/26/22 JPMorgan
BP downgraded to Neutral from Overweight at JPMorgan
09/12/22 Piper Sandler
BP price target raised to $47 from $44 at Piper Sandler
08/17/22 Morgan Stanley
BP price target raised to 566 GBp from 540 GBp at Morgan Stanley
08/08/22 Berenberg
BP price target lowered to 500 GBp from 510 GBp at Berenberg
PFS Provident Financial
$20.27 /

-2.915 (-12.58%)

08/19/22 Piper Sandler
Provident Financial downgraded to Neutral from Overweight at Piper Sandler
LBAI Lakeland Bancorp
$16.38 /

+0.07 (+0.43%)

07/07/22 Raymond James
Lakeland Bancorp downgraded to Outperform from Strong Buy at Raymond James
JBL Jabil
$57.40 /

+1.24 (+2.21%)

09/21/22 Citi
Citi opens 'positive 30-day catalyst watch' on Jabil into earnings
08/16/22 Credit Suisse
Jabil initiated with an Outperform at Credit Suisse
06/17/22 Citi
Jabil price target lowered to $80 from $90 at Citi
06/01/22 Goldman Sachs
Jabil price target lowered to $69 from $78 at Goldman Sachs
BIIB Biogen
$197.75 /

+1.985 (+1.01%)

09/28/22 UBS
Biogen lecanemab data is 'major development' in Alzheimer's disease, says UBS
09/28/22 Mizuho
Biogen upgraded to Buy from Neutral at Mizuho
09/28/22 Baird
Biogen upgraded to Outperform from Neutral at Baird
09/28/22 BMO Capital
Biogen upgraded to Outperform from Market Perform at BMO Capital
F Ford
$11.92 /

-0.08 (-0.67%)

09/28/22 Citi
Ford price target lowered to $13 from $16 at Citi
09/21/22 BofA
Lyft takeover speculation 'may be more hype than substance,' says BofA
09/20/22 Morgan Stanley
Morgan Stanley would be buyer on weakness in Ford below $14 per share
09/20/22 Citi
'Surprise' $1B cost headwind to weigh on Ford shares, says Citi
KDP Keurig Dr Pepper
$35.96 /

-1.325 (-3.55%)

09/27/22 Goldman Sachs
Keurig Dr Pepper downgraded to Neutral from Buy at Goldman Sachs
08/19/22 Jefferies
Jefferies concerned about potential Keurig acquisition of Vital
08/19/22 Bernstein
Keurig Dr Pepper may get Vital 'on the cheap,' says Bernstein
07/20/22 JPMorgan
Keurig Dr Pepper price target lowered to $42 from $44 at JPMorgan
H Hyatt
$80.56 /

+2.34 (+2.99%)

09/27/22 Evercore ISI
Hyatt upgraded to Outperform at Evercore ISI on re-rating potential
09/27/22 Evercore ISI
Hyatt upgraded to Outperform from In Line at Evercore ISI
09/15/22 Berenberg
Hyatt upgraded to Buy on lodging recovery at Berenberg
09/15/22 Berenberg
Hyatt upgraded to Buy from Hold at Berenberg
LCID Lucid Group
$14.42 /

+0.38 (+2.71%)

09/27/22 Cantor Fitzgerald
Lucid Group initiated with an Overweight at Cantor Fitzgerald
09/27/22 Cantor Fitzgerald
Lucid Group initiated with an Overweight at Cantor Fitzgerald
09/15/22 Citi
Lucid Group resumed with a Buy at Citi
09/14/22 Needham
Needham starts Lucid Group at Underperform on lack of profitability
CSX CSX
$27.23 /

-0.215 (-0.78%)

09/28/22 Susquehanna
CSX downgraded to Neutral from Positive at Susquehanna
09/27/22 UBS
CSX downgraded to Neutral from Buy at UBS
09/14/22 Bernstein
Bernstein downgrades CSX to Market Perform with $32 price target
09/14/22 Bernstein
CSX downgraded to Market Perform from Outperform at Bernstein
NSC Norfolk Southern
$213.86 /

-1.03 (-0.48%)

09/28/22 Susquehanna
Norfolk Southern downgraded to Neutral from Positive at Susquehanna
09/27/22 UBS
Norfolk Southern downgraded to Neutral from Buy at UBS
09/06/22 Citi
Citi opens 'negative catalyst watch' on Norfolk Southern
07/28/22 Cowen
Norfolk Southern price target lowered to $316 from $331 at Cowen
LEV Lion Electric
$2.98 /

+0.11 (+3.83%)

09/27/22 B. Riley
Lion Electric initiated with a Buy at B. Riley
08/24/22 Veritas
Lion Electric initiated with a Sell at Veritas
06/28/22 DA Davidson
Lion Electric initiated with a Buy at DA Davidson
06/10/22 Roth Capital
Lion Electric initiated with a Buy at Roth Capital
TSLA Tesla
$283.03 /

+7.2 (+2.61%)

09/28/22 Citi
Citi lowers Q3 deliveries estimate for Tesla, sees risk to Q4 numbers
09/20/22 Morgan Stanley
Tesla passing through 'peak China' dependency stage, says Morgan Stanley
09/16/22 Deutsche Bank
Tesla price target raised to $400 from $375 at Deutsche Bank
09/15/22 Wedbush
Biden focused EV initiatives step in right direction, says Wedbush
IHG InterContinental
$47.83 /

+0.69 (+1.46%)

09/16/22 Citi
InterContinental downgraded to Sell from Neutral at Citi
09/07/22 Deutsche Bank
InterContinental price target lowered to 5,520 GBp at Deutsche Bank
08/26/22 JPMorgan
InterContinental downgraded to Neutral on 'clear uncertainty' at JPMorgan
08/25/22 JPMorgan
InterContinental downgraded to Neutral from Overweight at JPMorgan
TSM TSMC
$72.98 /

-0.14 (-0.19%)

09/14/22 Daiwa
TSMC upgraded to Buy from Outperform at Daiwa
08/03/22 Northland
AMD price target raised to $105 from $95 at Northland
07/14/22 Susquehanna
TSMC price target lowered to $88 from $90 at Susquehanna
07/12/22 Citi
Citi sees estimate upside, 'upbeat' Q2 from TSMC
GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

09/12/22 Deutsche Bank
Goldman Sachs price target lowered to $370 from $430 at Deutsche Bank
09/06/22 Odeon Capital
Goldman Sachs downgraded to Sell from Hold at Odeon Capital
07/19/22 BMO Capital
Goldman Sachs price target lowered to $461 from $475 at BMO Capital
07/19/22 Barclays
Goldman Sachs price target lowered to $450 from $505 at Barclays
APO Apollo Global
$48.84 /

-0.08 (-0.16%)

09/23/22 BofA
Apollo Global upgraded to Neutral at BofA on more attractive valuation
09/23/22 BofA
Apollo Global upgraded to Neutral from Underperform at BofA
08/31/22 Barclays
Apollo Global initiated with an Overweight at Barclays
08/12/22 Deutsche Bank
Apollo Global price target lowered to $87 from $91 at Deutsche Bank
SKIN Beauty Health
$11.58 /

+1.18 (+11.35%)

09/27/22 Benchmark
Beauty Health buyback plans positive for stock, says Benchmark
09/16/22 JPMorgan
Beauty Health price target raised to $22 from $18 at JPMorgan
09/16/22 DA Davidson
Beauty Health price target raised to $30 from $25 at DA Davidson
09/16/22 Piper Sandler
Beauty Health price target raised to $23 from $20 at Piper Sandler
NVAX Novavax
$20.04 /

+1.18 (+6.26%)

09/22/22 JPMorgan
Novavax downgraded to Underweight from Neutral at JPMorgan
08/10/22 B. Riley
Novavax price target lowered to $126 from $171 at B. Riley
08/09/22 Cowen
Novavax price target lowered to $110 from $150 at Cowen
07/22/22 B. Riley
Novavax price target lowered to $171 from $181 at B. Riley
HROW Harrow Health
$9.74 /

+2.16 (+28.50%)

09/08/22 B. Riley
Harrow Health resumed with a Buy at B. Riley
05/20/22 B. Riley
Harrow Health price target raised to $20 from $17 at B. Riley
10/14/21 B. Riley
Harrow Health resumed with a Buy at B. Riley
10/14/21 B. Riley
Harrow Health resumed with a Buy at B. Riley
RNA Avidity Biosciences
$16.70 /

-2.07 (-11.03%)

09/27/22 Chardan
Avidity Biosciences price target lowered to $27 from $29 at Chardan
07/20/22 Chardan
Avidity Biosciences initiated with a Buy at Chardan
07/11/22 Raymond James
Avidity Biosciences initiated with a Strong Buy at Raymond James
OCUL Ocular Therapeutix
$4.29 /

-0.985 (-18.69%)

09/27/22 Piper Sandler
Ocular Therapeutix hit/beat on Phase I study expectations, says Piper Sandler
08/10/22 Berenberg
Ocular Therapeutix assumed with a Buy at Berenberg
05/27/22 Piper Sandler
Ocular Therapeutix price target lowered to $10 from $16 at Piper Sandler
05/10/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $10 from $14 at H.C. Wainwright
CBRL Cracker Barrel
$97.20 /

-0.66 (-0.67%)

09/28/22 Citi
Cracker Barrel price target lowered to $90 from $98 at Citi
09/23/22 Truist
Cracker Barrel price target raised to $100 from $94 at Truist
09/12/22 Citi
Cracker Barrel price target raised to $98 from $89 at Citi
08/02/22 Deutsche Bank
Deutsche downgrades Cracker Barrel with older diners staying away
UNFI United Natural Foods
$37.33 /

-1.135 (-2.95%)

09/21/22 Deutsche Bank
United Natural Foods price target raised to $54 from $53 at Deutsche Bank
06/29/22 Deutsche Bank
United Natural Foods price target raised to $53 from $46 at Deutsche Bank
06/08/22 MKM Partners
United Natural Foods price target raised to $69 from $66 at MKM Partners
04/27/22 CL King
SpartanNash rumored to be acquisition targe, says CL King
AVNT Avient
$31.04 /

-1.885 (-5.73%)

09/28/22 Oppenheimer
Avient downgraded to Perform from Outperform at Oppenheimer
07/27/22 Stifel
Avient price target lowered to $70 from $76 at Stifel
07/27/22 Baird
Avient price target lowered to $56 from $63 at Baird
07/07/22 Wells Fargo
Avient price target lowered to $53 from $65 at Wells Fargo
SNX TD Synnex
$84.39 /

+0.23 (+0.27%)

09/27/22 Credit Suisse
TD Synnex price target lowered to $103 from $110 at Credit Suisse
09/27/22 Stifel
TD Synnex price target lowered to $120 from $125 at Stifel
09/22/22 Citi
TD Synnex remains top IT distributor stock pick at Citi
09/14/22 Credit Suisse
TD Synnex price target lowered to $110 from $115 at Credit Suisse
SPLK Splunk
$80.38 /

+1.03 (+1.30%)

09/27/22 Canaccord
Splunk CFO departure unlikely to disrupt momentum, says Canaccord
09/27/22 Mizuho
Splunk price target lowered to $110 from $115 at Mizuho
08/31/22 Argus
Splunk price target lowered to $125 from $171 at Argus
08/25/22 Loop Capital
Splunk price target lowered to $135 from $160 at Loop Capital
R Ryder
$76.22 /

+9.625 (+14.45%)

06/06/22 Stifel
Ryder price target raised to $90 from $80 at Stifel
06/06/22 Wolfe Research
Ryder upgraded to Peer Perform from Underperform at Wolfe Research
06/06/22 Wells Fargo
Ryder price target raised to $81 from $68 at Wells Fargo
05/13/22 Stifel
Ryder offer from shareholder HG Vora Capital 'surprising,' says Stifel
UNFI United Natural Foods
$37.33 /

-1.135 (-2.95%)

TSM TSMC
$72.98 /

-0.14 (-0.19%)

TSLA Tesla
$283.03 /

+7.2 (+2.61%)

SPLK Splunk
$80.38 /

+1.03 (+1.30%)

SNX TD Synnex
$84.39 /

+0.23 (+0.27%)

SKIN Beauty Health
$11.58 /

+1.18 (+11.35%)

RNA Avidity Biosciences
$16.70 /

-2.07 (-11.03%)

R Ryder
$76.22 /

+9.625 (+14.45%)

PFS Provident Financial
$20.27 /

-2.915 (-12.58%)

OCUL Ocular Therapeutix
$4.29 /

-0.985 (-18.69%)

NVAX Novavax
$20.04 /

+1.18 (+6.26%)

NSC Norfolk Southern
$213.86 /

-1.03 (-0.48%)

LEV Lion Electric
$2.98 /

+0.11 (+3.83%)

LCID Lucid Group
$14.42 /

+0.38 (+2.71%)

LBAI Lakeland Bancorp
$16.38 /

+0.07 (+0.43%)

KDP Keurig Dr Pepper
$35.96 /

-1.325 (-3.55%)

JBL Jabil
$57.40 /

+1.24 (+2.21%)

HTZ Hertz
$16.50 /

+0.67 (+4.23%)

HROW Harrow Health
$9.74 /

+2.16 (+28.50%)

H Hyatt
$80.56 /

+2.34 (+2.99%)

GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

F Ford
$11.92 /

-0.08 (-0.67%)

CSX CSX
$27.23 /

-0.215 (-0.78%)

CBRL Cracker Barrel
$97.20 /

-0.66 (-0.67%)

BP BP
$27.56 /

+0.295 (+1.08%)

BIIB Biogen
$197.75 /

+1.985 (+1.01%)

AVNT Avient
$31.04 /

-1.885 (-5.73%)

APO Apollo Global
$48.84 /

-0.08 (-0.16%)

  • 09
    Nov
UNFI United Natural Foods
$37.33 /

-1.135 (-2.95%)

TSM TSMC
$72.98 /

-0.14 (-0.19%)

TSLA Tesla
$283.03 /

+7.2 (+2.61%)

NVAX Novavax
$20.04 /

+1.18 (+6.26%)

LCID Lucid Group
$14.42 /

+0.38 (+2.71%)

KDP Keurig Dr Pepper
$35.96 /

-1.325 (-3.55%)

IHG InterContinental
$47.83 /

+0.69 (+1.46%)

HTZ Hertz
$16.50 /

+0.67 (+4.23%)

GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

F Ford
$11.92 /

-0.08 (-0.67%)

CSX CSX
$27.23 /

-0.215 (-0.78%)

BP BP
$27.56 /

+0.295 (+1.08%)

APO Apollo Global
$48.84 /

-0.08 (-0.16%)

TSM TSMC
$72.98 /

-0.14 (-0.19%)

TSLA Tesla
$283.03 /

+7.2 (+2.61%)

SPLK Splunk
$80.38 /

+1.03 (+1.30%)

SNX TD Synnex
$84.39 /

+0.23 (+0.27%)

SKIN Beauty Health
$11.58 /

+1.18 (+11.35%)

RNA Avidity Biosciences
$16.70 /

-2.07 (-11.03%)

R Ryder
$76.22 /

+9.625 (+14.45%)

NVAX Novavax
$20.04 /

+1.18 (+6.26%)

LEV Lion Electric
$2.98 /

+0.11 (+3.83%)

KDP Keurig Dr Pepper
$35.96 /

-1.325 (-3.55%)

JBL Jabil
$57.40 /

+1.24 (+2.21%)

HTZ Hertz
$16.50 /

+0.67 (+4.23%)

H Hyatt
$80.56 /

+2.34 (+2.99%)

F Ford
$11.92 /

-0.08 (-0.67%)

CSX CSX
$27.23 /

-0.215 (-0.78%)

BP BP
$27.56 /

+0.295 (+1.08%)

BIIB Biogen
$197.75 /

+1.985 (+1.01%)

APO Apollo Global
$48.84 /

-0.08 (-0.16%)

TSM TSMC
$72.98 /

-0.14 (-0.19%)

TSLA Tesla
$283.03 /

+7.2 (+2.61%)

SPLK Splunk
$80.38 /

+1.03 (+1.30%)

NVAX Novavax
$20.04 /

+1.18 (+6.26%)

LEV Lion Electric
$2.98 /

+0.11 (+3.83%)

LCID Lucid Group
$14.42 /

+0.38 (+2.71%)

KDP Keurig Dr Pepper
$35.96 /

-1.325 (-3.55%)

HTZ Hertz
$16.50 /

+0.67 (+4.23%)

H Hyatt
$80.56 /

+2.34 (+2.99%)

GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

F Ford
$11.92 /

-0.08 (-0.67%)

CSX CSX
$27.23 /

-0.215 (-0.78%)

BP BP
$27.56 /

+0.295 (+1.08%)

BIIB Biogen
$197.75 /

+1.985 (+1.01%)

APO Apollo Global
$48.84 /

-0.08 (-0.16%)

On The Fly
What You Missed On Wall Street This Morning » 12:16
09/27/22
09/27
12:16
09/27/22
12:16
HTZ

Hertz

$16.60 /

+0.77 (+4.86%)

, BP

BP

$27.61 /

+0.345 (+1.27%)

, CBRL

Cracker Barrel

$98.58 /

+0.72 (+0.74%)

, PFS

Provident Financial

$20.35 /

-2.83 (-12.21%)

, LBAI

Lakeland Bancorp

$16.55 /

+0.24 (+1.47%)

, JBL

Jabil

$57.67 /

+1.505 (+2.68%)

, UNFI

United Natural Foods

$38.54 /

+0.08 (+0.21%)

, KDP

Keurig Dr Pepper

$36.35 /

-0.935 (-2.51%)

, H

Hyatt

$80.63 /

+2.41 (+3.08%)

, LCID

Lucid Group

$14.38 /

+0.34 (+2.42%)

, CSX

CSX

$27.10 /

-0.345 (-1.26%)

, NSC

Norfolk Southern

$213.35 /

-1.54 (-0.72%)

, LEV

Lion Electric

$2.99 /

+0.12 (+4.18%)

, TSLA

Tesla

$281.65 /

+5.82 (+2.11%)

, IHG

InterContinental

$48.17 /

+1.03 (+2.18%)

, TSM

TSMC

$72.91 /

-0.21 (-0.29%)

, GS

Goldman Sachs

$291.60 /

-3.11 (-1.06%)

, DWAC

Digital World Acquisition

$16.73 /

-0.83 (-4.73%)

, SKIN

Beauty Health

$11.72 /

+1.32 (+12.69%)

, NVAX

Novavax

$20.30 /

+1.44 (+7.64%)

, PENN

Penn Entertainment

$26.81 /

+0.67 (+2.56%)

, RNA

Avidity Biosciences

$15.78 /

-2.99 (-15.93%)

, OCUL

Ocular Therapeutix

$4.92 /

-0.355 (-6.74%)

, AVNT

Avient

$31.40 /

-1.52 (-4.62%)

, SNX

TD Synnex

$83.70 /

-0.46 (-0.55%)

, SPLK

Splunk

$79.81 /

+0.46 (+0.58%)

, FLT

FleetCor

$177.08 /

-3.88 (-2.14%)

, NEOG

Neogen

$14.38 /

-0.17 (-1.17%)

Get caught up quickly on…

ShowHide Related Items >><<
UNFI United Natural Foods
$38.54 /

+0.08 (+0.21%)

TSM TSMC
$72.91 /

-0.21 (-0.29%)

TSLA Tesla
$281.65 /

+5.82 (+2.11%)

SPLK Splunk
$79.81 /

+0.46 (+0.58%)

SNX TD Synnex
$83.70 /

-0.46 (-0.55%)

SKIN Beauty Health
$11.72 /

+1.32 (+12.69%)

RNA Avidity Biosciences
$15.78 /

-2.99 (-15.93%)

PFS Provident Financial
$20.35 /

-2.83 (-12.21%)

PENN Penn Entertainment
$26.81 /

+0.67 (+2.56%)

OCUL Ocular Therapeutix
$4.92 /

-0.355 (-6.74%)

NVAX Novavax
$20.30 /

+1.44 (+7.64%)

NSC Norfolk Southern
$213.35 /

-1.54 (-0.72%)

NEOG Neogen
$14.38 /

-0.17 (-1.17%)

LEV Lion Electric
$2.99 /

+0.12 (+4.18%)

LCID Lucid Group
$14.38 /

+0.34 (+2.42%)

LBAI Lakeland Bancorp
$16.55 /

+0.24 (+1.47%)

KDP Keurig Dr Pepper
$36.35 /

-0.935 (-2.51%)

JBL Jabil
$57.67 /

+1.505 (+2.68%)

IHG InterContinental
$48.17 /

+1.03 (+2.18%)

HTZ Hertz
$16.60 /

+0.77 (+4.86%)

H Hyatt
$80.63 /

+2.41 (+3.08%)

GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

FLT FleetCor
$177.08 /

-3.88 (-2.14%)

DWAC Digital World Acquisition
$16.73 /

-0.83 (-4.73%)

CSX CSX
$27.10 /

-0.345 (-1.26%)

CBRL Cracker Barrel
$98.58 /

+0.72 (+0.74%)

BP BP
$27.61 /

+0.345 (+1.27%)

AVNT Avient
$31.40 /

-1.52 (-4.62%)

HTZ Hertz
$16.60 /

+0.77 (+4.86%)

08/10/22 Tigress Financial
Tigress Financial raises Hertz price target to $34 on favorable industry trends
07/29/22 Deutsche Bank
Hertz price target raised to $38 from $29 at Deutsche Bank
07/14/22 Morgan Stanley
Hertz price target lowered to $16 from $23 at Morgan Stanley
07/13/22 Deutsche Bank
Hertz price target lowered to $29 from $36 at Deutsche Bank
BP BP
$27.61 /

+0.345 (+1.27%)

09/26/22 JPMorgan
BP downgraded to Neutral from Overweight at JPMorgan
09/12/22 Piper Sandler
BP price target raised to $47 from $44 at Piper Sandler
08/17/22 Morgan Stanley
BP price target raised to 566 GBp from 540 GBp at Morgan Stanley
08/08/22 Berenberg
BP price target lowered to 500 GBp from 510 GBp at Berenberg
CBRL Cracker Barrel
$98.58 /

+0.72 (+0.74%)

09/23/22 Truist
Cracker Barrel price target raised to $100 from $94 at Truist
09/12/22 Citi
Cracker Barrel price target raised to $98 from $89 at Citi
08/02/22 Deutsche Bank
Deutsche downgrades Cracker Barrel with older diners staying away
08/02/22 Deutsche Bank
Cracker Barrel downgraded to Hold from Buy at Deutsche Bank
PFS Provident Financial
$20.35 /

-2.83 (-12.21%)

08/19/22 Piper Sandler
Provident Financial downgraded to Neutral from Overweight at Piper Sandler
LBAI Lakeland Bancorp
$16.55 /

+0.24 (+1.47%)

07/07/22 Raymond James
Lakeland Bancorp downgraded to Outperform from Strong Buy at Raymond James
JBL Jabil
$57.67 /

+1.505 (+2.68%)

09/21/22 Citi
Citi opens 'positive 30-day catalyst watch' on Jabil into earnings
08/16/22 Credit Suisse
Jabil initiated with an Outperform at Credit Suisse
06/17/22 Citi
Jabil price target lowered to $80 from $90 at Citi
06/01/22 Goldman Sachs
Jabil price target lowered to $69 from $78 at Goldman Sachs
UNFI United Natural Foods
$38.54 /

+0.08 (+0.21%)

09/21/22 Deutsche Bank
United Natural Foods price target raised to $54 from $53 at Deutsche Bank
06/29/22 Deutsche Bank
United Natural Foods price target raised to $53 from $46 at Deutsche Bank
06/08/22 MKM Partners
United Natural Foods price target raised to $69 from $66 at MKM Partners
04/27/22 CL King
SpartanNash rumored to be acquisition targe, says CL King
KDP Keurig Dr Pepper
$36.35 /

-0.935 (-2.51%)

09/27/22 Goldman Sachs
Keurig Dr Pepper downgraded to Neutral from Buy at Goldman Sachs
08/19/22 Jefferies
Jefferies concerned about potential Keurig acquisition of Vital
08/19/22 Bernstein
Keurig Dr Pepper may get Vital 'on the cheap,' says Bernstein
07/20/22 JPMorgan
Keurig Dr Pepper price target lowered to $42 from $44 at JPMorgan
H Hyatt
$80.63 /

+2.41 (+3.08%)

09/27/22 Evercore ISI
Hyatt upgraded to Outperform at Evercore ISI on re-rating potential
09/27/22 Evercore ISI
Hyatt upgraded to Outperform from In Line at Evercore ISI
09/15/22 Berenberg
Hyatt upgraded to Buy on lodging recovery at Berenberg
09/15/22 Berenberg
Hyatt upgraded to Buy from Hold at Berenberg
LCID Lucid Group
$14.38 /

+0.34 (+2.42%)

09/27/22 Cantor Fitzgerald
Lucid Group initiated with an Overweight at Cantor Fitzgerald
09/27/22 Cantor Fitzgerald
Lucid Group initiated with an Overweight at Cantor Fitzgerald
09/15/22 Citi
Lucid Group resumed with a Buy at Citi
09/14/22 Needham
Needham starts Lucid Group at Underperform on lack of profitability
CSX CSX
$27.10 /

-0.345 (-1.26%)

09/27/22 UBS
CSX downgraded to Neutral from Buy at UBS
09/14/22 Bernstein
Bernstein downgrades CSX to Market Perform with $32 price target
09/14/22 Bernstein
CSX downgraded to Market Perform from Outperform at Bernstein
07/21/22 Cowen
CSX price target lowered to $37 from $39 at Cowen
NSC Norfolk Southern
$213.35 /

-1.54 (-0.72%)

09/27/22 UBS
Norfolk Southern downgraded to Neutral from Buy at UBS
09/06/22 Citi
Citi opens 'negative catalyst watch' on Norfolk Southern
07/28/22 Cowen
Norfolk Southern price target lowered to $316 from $331 at Cowen
07/28/22 Credit Suisse
Norfolk Southern price target raised to $277 from $267 at Credit Suisse
LEV Lion Electric
$2.99 /

+0.12 (+4.18%)

09/27/22 B. Riley
Lion Electric initiated with a Buy at B. Riley
08/24/22 Veritas
Lion Electric initiated with a Sell at Veritas
06/28/22 DA Davidson
Lion Electric initiated with a Buy at DA Davidson
06/10/22 Roth Capital
Lion Electric initiated with a Buy at Roth Capital
TSLA Tesla
$281.65 /

+5.82 (+2.11%)

09/20/22 Morgan Stanley
Tesla passing through 'peak China' dependency stage, says Morgan Stanley
09/16/22 Deutsche Bank
Tesla price target raised to $400 from $375 at Deutsche Bank
09/15/22 Wedbush
Biden focused EV initiatives step in right direction, says Wedbush
09/14/22 Needham
Tesla assumed at Hold as Needham doesn't see catalyst for underperformance
IHG InterContinental
$48.17 /

+1.03 (+2.18%)

09/16/22 Citi
InterContinental downgraded to Sell from Neutral at Citi
09/07/22 Deutsche Bank
InterContinental price target lowered to 5,520 GBp at Deutsche Bank
08/26/22 JPMorgan
InterContinental downgraded to Neutral on 'clear uncertainty' at JPMorgan
08/25/22 JPMorgan
InterContinental downgraded to Neutral from Overweight at JPMorgan
TSM TSMC
$72.91 /

-0.21 (-0.29%)

09/14/22 Daiwa
TSMC upgraded to Buy from Outperform at Daiwa
08/03/22 Northland
AMD price target raised to $105 from $95 at Northland
07/14/22 Susquehanna
TSMC price target lowered to $88 from $90 at Susquehanna
07/12/22 Citi
Citi sees estimate upside, 'upbeat' Q2 from TSMC
GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

09/12/22 Deutsche Bank
Goldman Sachs price target lowered to $370 from $430 at Deutsche Bank
09/06/22 Odeon Capital
Goldman Sachs downgraded to Sell from Hold at Odeon Capital
07/19/22 BMO Capital
Goldman Sachs price target lowered to $461 from $475 at BMO Capital
07/19/22 Barclays
Goldman Sachs price target lowered to $450 from $505 at Barclays
DWAC Digital World Acquisition
$16.73 /

-0.83 (-4.73%)

SKIN Beauty Health
$11.72 /

+1.32 (+12.69%)

09/27/22 Benchmark
Beauty Health buyback plans positive for stock, says Benchmark
09/16/22 JPMorgan
Beauty Health price target raised to $22 from $18 at JPMorgan
09/16/22 DA Davidson
Beauty Health price target raised to $30 from $25 at DA Davidson
09/16/22 Piper Sandler
Beauty Health price target raised to $23 from $20 at Piper Sandler
NVAX Novavax
$20.30 /

+1.44 (+7.64%)

09/22/22 JPMorgan
Novavax downgraded to Underweight from Neutral at JPMorgan
08/10/22 B. Riley
Novavax price target lowered to $126 from $171 at B. Riley
08/09/22 Cowen
Novavax price target lowered to $110 from $150 at Cowen
07/22/22 B. Riley
Novavax price target lowered to $171 from $181 at B. Riley
PENN Penn Entertainment
$26.81 /

+0.67 (+2.56%)

08/17/22 Roth Capital
Roth Capital upgrades DraftKings to Buy, raises price target to $25
08/05/22 Stifel
Penn Entertainment price target lowered to $45 from $50 at Stifel
08/05/22 Barclays
Penn National price target raised to $44 from $37 at Barclays
07/20/22 Truist
Penn National price target lowered to $48 from $60 at Truist
RNA Avidity Biosciences
$15.78 /

-2.99 (-15.93%)

07/20/22 Chardan
Avidity Biosciences initiated with a Buy at Chardan
07/11/22 Raymond James
Avidity Biosciences initiated with a Strong Buy at Raymond James
OCUL Ocular Therapeutix
$4.92 /

-0.355 (-6.74%)

09/27/22 Piper Sandler
Ocular Therapeutix hit/beat on Phase I study expectations, says Piper Sandler
08/10/22 Berenberg
Ocular Therapeutix assumed with a Buy at Berenberg
05/27/22 Piper Sandler
Ocular Therapeutix price target lowered to $10 from $16 at Piper Sandler
05/10/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $10 from $14 at H.C. Wainwright
AVNT Avient
$31.40 /

-1.52 (-4.62%)

07/27/22 Stifel
Avient price target lowered to $70 from $76 at Stifel
07/27/22 Baird
Avient price target lowered to $56 from $63 at Baird
07/07/22 Wells Fargo
Avient price target lowered to $53 from $65 at Wells Fargo
06/28/22 Jefferies
Avient price target lowered to $51 from $67 at Jefferies
SNX TD Synnex
$83.70 /

-0.46 (-0.55%)

09/22/22 Citi
TD Synnex remains top IT distributor stock pick at Citi
09/14/22 Credit Suisse
TD Synnex price target lowered to $110 from $115 at Credit Suisse
08/16/22 Credit Suisse
TD Synnex initiated with a Neutral at Credit Suisse
07/14/22 JPMorgan
TD Synnex initiated with an Overweight at JPMorgan
SPLK Splunk
$79.81 /

+0.46 (+0.58%)

09/27/22 Canaccord
Splunk CFO departure unlikely to disrupt momentum, says Canaccord
09/27/22 Mizuho
Splunk price target lowered to $110 from $115 at Mizuho
08/31/22 Argus
Splunk price target lowered to $125 from $171 at Argus
08/25/22 Loop Capital
Splunk price target lowered to $135 from $160 at Loop Capital
FLT FleetCor
$177.08 /

-3.88 (-2.14%)

09/27/22 Jefferies
FleetCor Q3 reiteration 'silver lining' in surprise CFO exit, says Jefferies
09/26/22 Baird
FleetCor price target lowered to $220 from $250 at Baird
09/15/22 Barclays
FleetCor price target lowered to $290 from $295 at Barclays
08/09/22 Mizuho
FleetCor price target raised to $256 from $250 at Mizuho
NEOG Neogen
$14.38 /

-0.17 (-1.17%)

09/27/22 Piper Sandler
Neogen quarter 'somewhat disappointing,' says Piper Sandler
08/30/22 Piper Sandler
Neogen price target lowered to $20 from $26 at Piper Sandler
08/01/22 Piper Sandler
Neogen price target raised to $26 from $25 at Piper Sandler
07/11/22 Piper Sandler
Neogen initiated with a Neutral at Piper Sandler
UNFI United Natural Foods
$38.54 /

+0.08 (+0.21%)

TSM TSMC
$72.91 /

-0.21 (-0.29%)

TSLA Tesla
$281.65 /

+5.82 (+2.11%)

SPLK Splunk
$79.81 /

+0.46 (+0.58%)

SNX TD Synnex
$83.70 /

-0.46 (-0.55%)

SKIN Beauty Health
$11.72 /

+1.32 (+12.69%)

RNA Avidity Biosciences
$15.78 /

-2.99 (-15.93%)

PFS Provident Financial
$20.35 /

-2.83 (-12.21%)

PENN Penn Entertainment
$26.81 /

+0.67 (+2.56%)

OCUL Ocular Therapeutix
$4.92 /

-0.355 (-6.74%)

NVAX Novavax
$20.30 /

+1.44 (+7.64%)

NSC Norfolk Southern
$213.35 /

-1.54 (-0.72%)

NEOG Neogen
$14.38 /

-0.17 (-1.17%)

LEV Lion Electric
$2.99 /

+0.12 (+4.18%)

LCID Lucid Group
$14.38 /

+0.34 (+2.42%)

LBAI Lakeland Bancorp
$16.55 /

+0.24 (+1.47%)

KDP Keurig Dr Pepper
$36.35 /

-0.935 (-2.51%)

JBL Jabil
$57.67 /

+1.505 (+2.68%)

HTZ Hertz
$16.60 /

+0.77 (+4.86%)

H Hyatt
$80.63 /

+2.41 (+3.08%)

GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

FLT FleetCor
$177.08 /

-3.88 (-2.14%)

CSX CSX
$27.10 /

-0.345 (-1.26%)

CBRL Cracker Barrel
$98.58 /

+0.72 (+0.74%)

BP BP
$27.61 /

+0.345 (+1.27%)

AVNT Avient
$31.40 /

-1.52 (-4.62%)

  • 09
    Nov
UNFI United Natural Foods
$38.54 /

+0.08 (+0.21%)

TSM TSMC
$72.91 /

-0.21 (-0.29%)

TSLA Tesla
$281.65 /

+5.82 (+2.11%)

PENN Penn Entertainment
$26.81 /

+0.67 (+2.56%)

NVAX Novavax
$20.30 /

+1.44 (+7.64%)

LCID Lucid Group
$14.38 /

+0.34 (+2.42%)

KDP Keurig Dr Pepper
$36.35 /

-0.935 (-2.51%)

IHG InterContinental
$48.17 /

+1.03 (+2.18%)

HTZ Hertz
$16.60 /

+0.77 (+4.86%)

GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

DWAC Digital World Acquisition
$16.73 /

-0.83 (-4.73%)

CSX CSX
$27.10 /

-0.345 (-1.26%)

BP BP
$27.61 /

+0.345 (+1.27%)

TSM TSMC
$72.91 /

-0.21 (-0.29%)

TSLA Tesla
$281.65 /

+5.82 (+2.11%)

SPLK Splunk
$79.81 /

+0.46 (+0.58%)

SNX TD Synnex
$83.70 /

-0.46 (-0.55%)

SKIN Beauty Health
$11.72 /

+1.32 (+12.69%)

RNA Avidity Biosciences
$15.78 /

-2.99 (-15.93%)

PENN Penn Entertainment
$26.81 /

+0.67 (+2.56%)

NVAX Novavax
$20.30 /

+1.44 (+7.64%)

NSC Norfolk Southern
$213.35 /

-1.54 (-0.72%)

LEV Lion Electric
$2.99 /

+0.12 (+4.18%)

LCID Lucid Group
$14.38 /

+0.34 (+2.42%)

KDP Keurig Dr Pepper
$36.35 /

-0.935 (-2.51%)

JBL Jabil
$57.67 /

+1.505 (+2.68%)

HTZ Hertz
$16.60 /

+0.77 (+4.86%)

H Hyatt
$80.63 /

+2.41 (+3.08%)

GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

FLT FleetCor
$177.08 /

-3.88 (-2.14%)

DWAC Digital World Acquisition
$16.73 /

-0.83 (-4.73%)

CSX CSX
$27.10 /

-0.345 (-1.26%)

CBRL Cracker Barrel
$98.58 /

+0.72 (+0.74%)

BP BP
$27.61 /

+0.345 (+1.27%)

TSM TSMC
$72.91 /

-0.21 (-0.29%)

TSLA Tesla
$281.65 /

+5.82 (+2.11%)

SPLK Splunk
$79.81 /

+0.46 (+0.58%)

PENN Penn Entertainment
$26.81 /

+0.67 (+2.56%)

NVAX Novavax
$20.30 /

+1.44 (+7.64%)

NEOG Neogen
$14.38 /

-0.17 (-1.17%)

LEV Lion Electric
$2.99 /

+0.12 (+4.18%)

LCID Lucid Group
$14.38 /

+0.34 (+2.42%)

KDP Keurig Dr Pepper
$36.35 /

-0.935 (-2.51%)

HTZ Hertz
$16.60 /

+0.77 (+4.86%)

H Hyatt
$80.63 /

+2.41 (+3.08%)

GS Goldman Sachs
$291.60 /

-3.11 (-1.06%)

DWAC Digital World Acquisition
$16.73 /

-0.83 (-4.73%)

CSX CSX
$27.10 /

-0.345 (-1.26%)

BP BP
$27.61 /

+0.345 (+1.27%)

Recommendations
Ocular Therapeutix hit/beat on Phase I study expectations, says Piper Sandler » 11:00
09/27/22
09/27
11:00
09/27/22
11:00
OCUL

Ocular Therapeutix

$5.10 /

-0.17 (-3.23%)

Piper Sandler analyst…

Piper Sandler analyst Joseph Catanzaro keeps an Overweight rating and $10 price target on shares of Ocular Therapeutix after the company reported topline data from OTX-TKI's Phase I randomized study in wAMD. All efficacy metrics hit or beat expectations in the study, Catanzaro tells investors in a research note, adding that these data solidify OTX-TKI as a best-in-class program and have it very well-positioned for future development.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$5.10 /

-0.17 (-3.23%)

OCUL Ocular Therapeutix
$5.10 /

-0.17 (-3.23%)

08/10/22 Berenberg
Ocular Therapeutix assumed with a Buy at Berenberg
05/27/22 Piper Sandler
Ocular Therapeutix price target lowered to $10 from $16 at Piper Sandler
05/10/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $10 from $14 at H.C. Wainwright
05/10/22 Piper Sandler
Ocular Therapeutix price target lowered to $16 from $20 at Piper Sandler
OCUL Ocular Therapeutix
$5.10 /

-0.17 (-3.23%)

Hot Stocks
Ocular Therapeutix up 15% after data from Phase 1 clinical trial of OTX-TKI » 08:08
09/27/22
09/27
08:08
09/27/22
08:08
OCUL

Ocular Therapeutix

$5.27 /

-0.03 (-0.57%)

Shares of Ocular…

Shares of Ocular Therapeutix are up 81c or 15.3% at $6.09 after the company reported interim data form Phase 1 clinical trial of OTX-TKI.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$5.27 /

-0.03 (-0.57%)

OCUL Ocular Therapeutix
$5.27 /

-0.03 (-0.57%)

08/10/22 Berenberg
Ocular Therapeutix assumed with a Buy at Berenberg
05/27/22 Piper Sandler
Ocular Therapeutix price target lowered to $10 from $16 at Piper Sandler
05/10/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $10 from $14 at H.C. Wainwright
05/10/22 Piper Sandler
Ocular Therapeutix price target lowered to $16 from $20 at Piper Sandler
OCUL Ocular Therapeutix
$5.27 /

-0.03 (-0.57%)

Hot Stocks
Ocular Therapeutix reports interim data form Phase 1 clinical trial of OTX-TKI » 06:03
09/27/22
09/27
06:03
09/27/22
06:03
OCUL

Ocular Therapeutix

$5.27 /

-0.03 (-0.57%)

Ocular Therapeutix…

Ocular Therapeutix announced interim 7-month data from its U.S. Phase 1 clinical trial evaluating OTX-TKI, the Company's axitinib intravitreal hydrogel implant being developed for the treatment of wet age-related macular degeneration, or wet AMD, and other retinal diseases. The data will be presented in more detail at the upcoming American Academy of Ophthalmology 2022 Annual Meeting Subspecialty Day being held in Chicago by Dilsher Dhoot, MD on Friday, September 30th and can be accessed approximately two hours after the presentation's conclusion. "These interim results from our U.S.-based Phase 1 trial of OTX-TKI for the treatment of wet AMD represent a significant milestone for Ocular," said Antony Mattessich, President and CEO. "Wet AMD is a leading cause of blindness affecting approximately 14 million individuals globally and approximately 2 million in the U.S. alone. The data presented today highlights the potential of OTX-TKI to become a highly-differentiated product capable of providing a durable anti-VEGF response that improves upon today's standard of care in the management of wet AMD and with potential in other retinal diseases. We look forward to discussing our future development plans with the FDA and, subject to those discussions, plan to initiate a Phase 2 clinical trial in the third quarter of 2023." Based on the data cutoff of August 24, 2022, interim data from the U.S.-based Phase 1 clinical trial showed that the single OTX-TKI implant was generally well tolerated with a favorable safety profile. There were no drug-related ocular or systemic serious adverse events observed.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$5.27 /

-0.03 (-0.57%)

OCUL Ocular Therapeutix
$5.27 /

-0.03 (-0.57%)

08/10/22 Berenberg
Ocular Therapeutix assumed with a Buy at Berenberg
05/27/22 Piper Sandler
Ocular Therapeutix price target lowered to $10 from $16 at Piper Sandler
05/10/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $10 from $14 at H.C. Wainwright
05/10/22 Piper Sandler
Ocular Therapeutix price target lowered to $16 from $20 at Piper Sandler
OCUL Ocular Therapeutix
$5.27 /

-0.03 (-0.57%)

Over a month ago
Conference/Events
Ocular Therapeutix management to meet virtually with Piper Sandler » 04:55
08/16/22
08/16
04:55
08/16/22
04:55
OCUL

Ocular Therapeutix

$5.49 /

+0.025 (+0.46%)

Virtual Meeting to be…

Virtual Meeting to be held on August 16 hosted by Piper Sandler.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$5.49 /

+0.025 (+0.46%)

OCUL Ocular Therapeutix
$5.49 /

+0.025 (+0.46%)

08/10/22 Berenberg
Ocular Therapeutix assumed with a Buy at Berenberg
05/27/22 Piper Sandler
Ocular Therapeutix price target lowered to $10 from $16 at Piper Sandler
05/10/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $10 from $14 at H.C. Wainwright
05/10/22 Piper Sandler
Ocular Therapeutix price target lowered to $16 from $20 at Piper Sandler
OCUL Ocular Therapeutix
$5.49 /

+0.025 (+0.46%)

Conference/Events
Ocular Therapeutix management to meet virtually with Piper Sandler » 15:21
08/10/22
08/10
15:21
08/10/22
15:21
OCUL

Ocular Therapeutix

$5.65 /

+0.75 (+15.31%)

Virtual Meeting to be…

Virtual Meeting to be held on August 16 hosted by Piper Sandler.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$5.65 /

+0.75 (+15.31%)

OCUL Ocular Therapeutix
$5.65 /

+0.75 (+15.31%)

08/10/22 Berenberg
Ocular Therapeutix assumed with a Buy at Berenberg
05/27/22 Piper Sandler
Ocular Therapeutix price target lowered to $10 from $16 at Piper Sandler
05/10/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $10 from $14 at H.C. Wainwright
05/10/22 Piper Sandler
Ocular Therapeutix price target lowered to $16 from $20 at Piper Sandler
OCUL Ocular Therapeutix
$5.65 /

+0.75 (+15.31%)

Initiation
Ocular Therapeutix assumed with a Buy at Berenberg » 07:00
08/10/22
08/10
07:00
08/10/22
07:00
OCUL

Ocular Therapeutix

$4.90 /

-0.145 (-2.87%)

Berenberg analyst…

Berenberg analyst Caroline Palomeque assumed coverage of Ocular Therapeutix with a Buy rating and $15 price target. Dextenza, a dexamethasone ophthalmic insert for post-surgical ocular inflammation and pain, had 27,000 billable units and product revenue grew 9% year-over-year to $12.1M in Q2. The analyst views this as an "encouraging development" given the environment around Part B reimbursement. She awaits the interim 28-week data from the Phase 1 trial of OTX-TKI in wet-age related macular degeneration at the end of September.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$4.90 /

-0.145 (-2.87%)

OCUL Ocular Therapeutix
$4.90 /

-0.145 (-2.87%)

05/27/22 Piper Sandler
Ocular Therapeutix price target lowered to $10 from $16 at Piper Sandler
05/10/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $10 from $14 at H.C. Wainwright
05/10/22 Piper Sandler
Ocular Therapeutix price target lowered to $16 from $20 at Piper Sandler
12/06/21 Piper Sandler
Ocular data warrant advancing acute dry eye program, says Piper Sandler
OCUL Ocular Therapeutix
$4.90 /

-0.145 (-2.87%)

Earnings
Ocular Therapeutix sees FY22 revenue $55M-$60M, consensus $60.9M » 16:09
08/08/22
08/08
16:09
08/08/22
16:09
OCUL

Ocular Therapeutix

$5.08 /

+0.125 (+2.53%)

As of June 30, 2022, the…

As of June 30, 2022, the Company had $134.5 million in cash and cash equivalents versus $145.4 million at March 31, 2022. Based on current plans and related estimates of anticipated cash inflows from DEXTENZA and anticipated cash outflows from operating expenses, the Company believes that its existing cash and cash equivalents are sufficient to enable the Company to fund planned operating expenses, debt service obligations and capital expenditure requirements through 2023. This cash guidance is subject to a number of assumptions including the impacts from the ongoing COVID-19 pandemic; the revenues, expenses and reimbursement associated with DEXTENZA; and the pace of research and clinical development programs, among other aspects of the business.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$5.08 /

+0.125 (+2.53%)

OCUL Ocular Therapeutix
$5.08 /

+0.125 (+2.53%)

05/27/22 Piper Sandler
Ocular Therapeutix price target lowered to $10 from $16 at Piper Sandler
05/10/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $10 from $14 at H.C. Wainwright
05/10/22 Piper Sandler
Ocular Therapeutix price target lowered to $16 from $20 at Piper Sandler
12/06/21 Piper Sandler
Ocular data warrant advancing acute dry eye program, says Piper Sandler
OCUL Ocular Therapeutix
$5.08 /

+0.125 (+2.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.